These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Fixed drug eruption caused by sulfaguanidine. Arias J; Fernández-Rivas M; Martinez M; Senent C Dermatology; 1994; 189(2):196-7. PubMed ID: 8075454 [TBL] [Abstract][Full Text] [Related]
5. Pigmented purpuric dermatosis after taking a dietary supplement. Unal E; Ergül G Cutan Ocul Toxicol; 2016 Sep; 35(3):260-2. PubMed ID: 26555283 [TBL] [Abstract][Full Text] [Related]
7. Pigmented purpuric dermatosis due to pseudoephedrine. Díaz-Jara M; Tornero P; Barrio MD; Vicente ME; Fuentes V; Barranco R Contact Dermatitis; 2002 May; 46(5):300-1. PubMed ID: 12084086 [No Abstract] [Full Text] [Related]
8. Fixed drug eruption caused by tolphenamic acid. Autio P; Stubb S Acta Derm Venereol; 1994 Jan; 74(1):76. PubMed ID: 7908495 [No Abstract] [Full Text] [Related]
9. A case of isotretinoin-induced purpura annularis telangiectodes of Majocchi and review of substance-induced pigmented purpuric dermatosis. Kaplan R; Meehan SA; Leger M JAMA Dermatol; 2014 Feb; 150(2):182-4. PubMed ID: 24284887 [TBL] [Abstract][Full Text] [Related]
10. Pigmented purpuric eruptions of childhood: a series of cases and review of literature. Tristani-Firouzi P; Meadows KP; Vanderhooft S Pediatr Dermatol; 2001; 18(4):299-304. PubMed ID: 11576402 [TBL] [Abstract][Full Text] [Related]
11. Pigmented purpuric dermatosis in an infant. Martos-Cabrera L; López-Balboa P; Ramírez-Lluch M; Colmenero I; Mateos-Mayo A; Torrelo A; Hernández-Martin Á Pediatr Dermatol; 2021 Mar; 38(2):504-505. PubMed ID: 33403710 [TBL] [Abstract][Full Text] [Related]
12. Cutaneous drug reactions: pathogenesis and clinical classification. Wintroub BU; Stern R J Am Acad Dermatol; 1985 Aug; 13(2 Pt 1):167-79. PubMed ID: 2931455 [TBL] [Abstract][Full Text] [Related]